ImmuCell (ICCC) vs QuidelOrtho (QDEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ImmuCell (ICCC) has outperformed QuidelOrtho (QDEL) over the past year, gaining 50.2% versus a loss of 55.5%. Over five years, ICCC leads with a +4.4% price change compared with -90.3% for QDEL. QuidelOrtho is the larger company by market cap ($851.0 million vs $88.6 million), about 9.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCC | QDEL |
|---|---|---|
| Share price | $9.75 | $12.41 |
| Market cap | $88.55M | $851.02M |
| 1-day change | +0.62% | +0.81% |
| YTD return | +57.56% | -56.55% |
| 1-year return | +50.23% | -55.46% |
| 5-year return | +4.42% | -90.32% |
| P/E ratio (TTM) | 139.29 | — |
| Forward P/E | — | 8.61 |
| EPS (TTM) | $0.07 | $-15.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.10 | $35.58 |
| 52-week low | $4.52 | $9.92 |
| Distance from 52-week high | -19.42% | -65.12% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | +18.21% |
| Average volume | 22.20K | 1.51M |
| Shares outstanding | 9.08M | 68.58M |
| Employees | 73 | 6,500 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QuidelOrtho is about 9.6 times larger than ImmuCell by market value ($851.02M vs $88.55M).
- ICCC has outperformed QDEL by 105.7 percentage points over the past year.
- The two companies sit in different sectors: ImmuCell in Healthcare and QuidelOrtho in Health Care.
About ImmuCell
ICCC stock →ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis.
Healthcare · Biotechnology · 73 employees
About QuidelOrtho
QDEL stock →QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 6,500 employees
ICCC vs QDEL FAQ
Which is bigger, ImmuCell or QuidelOrtho?
QuidelOrtho (QDEL) is larger, with a market capitalization of $851.02M compared with $88.55M for ImmuCell (ICCC).
Which stock has performed better over the past year, ICCC or QDEL?
ICCC returned +50.23% over the past 12 months, compared with -55.46% for QDEL (price return, excluding dividends). Past performance does not predict future results.
Are ImmuCell and QuidelOrtho in the same industry?
No. ImmuCell is in the Healthcare sector, while QuidelOrtho is in Health Care.